Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 10Libtayo
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 81
2019 Revenue in Millions : 213
Growth (%) : -62
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 142
2020 Revenue in Millions : 73
Growth (%) : 93
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 97
2021 Revenue in Millions : 142
Growth (%) : -32
Main Therapeutic Indication : Oncology
Currency : USD
2019 Revenue in Millions : 176
2018 Revenue in Millions : 15
Growth (%) : 1,087
Main Therapeutic Indication : Oncology
Currency : USD
2020 Revenue in Millions : 271
2019 Revenue in Millions : 176
Growth (%) : 54
Main Therapeutic Indication : Oncology
Currency : USD
2021 Revenue in Millions : 306
2020 Revenue in Millions : 271
Growth (%) : 13
Main Therapeutic Indication : Oncology
Currency : USD
2022 Revenue in Millions : 448
2021 Revenue in Millions : 306
Growth (%) : 46
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 863
2022 Revenue in Millions : 448
Growth (%) : 93
Main Therapeutic Indication : Oncology
Currency : USD
2024 Revenue in Millions : 1,217
2023 Revenue in Millions : 863
Growth (%) : 41
Main Therapeutic Indication : Oncology
Currency : USD
2018 Revenue in Millions : 15
2017 Revenue in Millions : 0
Growth (%) : New Launch
